{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:24:02Z","timestamp":1776857042084,"version":"3.51.2"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      Hypereosinophilia (HE) is a rare disease with complex and diverse causes. Therapeutic strategies for HE differ because of its diverse causes, demanding advanced diagnostic tools for accurate assessment. This study evaluated the role of\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT) in determining the etiology of HE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This retrospective single-center study consecutively included 78 patients with HE who underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT examinations between 2011 and 2022. The diagnostic value of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in identifying the etiology of HE was assessed. Logistic regression analyses were conducted to determine the clinical and laboratory factors associated with\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Seventy-eight patients aged 44.58\u00b117.01 years had different conditions: infectious diseases, n=9 [11.54%]; noninfectious inflammatory diseases, n=23 [29.49%]; solid tumors or hematological malignancies, n=16 [20.51%]; lymphocyte-variant HE, n=1 [1.28%]; and idiopathic HE or idiopathic hypereosinophilic syndrome, n=29 [37.18%].\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT was used to identify the etiology in 48 patients (61.54%, true positive), whereas secondary causes were ruled out in 21 patients (26.92%), leading to a diagnosis of idiopathic HE.\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT achieved a diagnostic sensitivity of 92.31%, specificity of 80.77%, and accuracy of 88.46%. The presence of symptoms was positively correlated with true-positive PET\/CT results (odds ratio: 2.940, 95% CI: 1.073\u20138.055), whereas immunoglobulin E level exhibited no association.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT showed high sensitivity and accuracy in identifying the etiology of HE, making it a valuable tool for assessing elevated eosinophil counts.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006177","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:00:19Z","timestamp":1764255619000},"page":"e84-e91","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Utility of 18F-FDG PET\/CT in Patients With Hypereosinophilia"],"prefix":"10.1097","volume":"51","author":[{"given":"Bing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3761-4332","authenticated-orcid":false,"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ajh.27287","article-title":"World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Shomali","year":"2024","journal-title":"Am J Hematol"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13023-023-02696-4","article-title":"French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes","volume":"18","author":"Groh","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cpet.2022.02.004","article-title":"Utility of PET\/computed tomography in infection and inflammation imaging","volume":"17","author":"Jaleel","year":"2022","journal-title":"PET Clin"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/rheumatology\/keab675","article-title":"2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases","volume":"61","author":"Subesinghe","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","article-title":"Advances in PET imaging of cancer","volume":"23","author":"Schwenck","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2352-3026(20)30357-4","article-title":"The role of PET in first-line treatment of Hodgkin lymphoma","volume":"8","author":"Trotman","year":"2021","journal-title":"Lancet Haematol"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2352-3026(20)30365-3","article-title":"The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma","volume":"8","author":"Barrington","year":"2021","journal-title":"Lancet Haematol"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00261-009-9513-z","article-title":"Fluorine-18-FDG PET findings of focal eosinophilic liver disease: correlation with CT and\/or MRI, laboratory, and pathologic findings","volume":"35","author":"Kim","year":"2010","journal-title":"Abdom Imaging"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00259-013-2412-0","article-title":"Detection of multiple muscle involvement in eosinophilic myositis with 18F-FDG PET\/CT","volume":"40","author":"Chen","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/RLU.0b013e318286c025","article-title":"FDG PET\/CT in eosinophilic esophagitis","volume":"39","author":"Dong","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2169\/internalmedicine.55.6937","article-title":"Eosinophilic fasciitis illustrated by [(18)F] FDG-PET\/CT","volume":"55","author":"Kurimoto","year":"2016","journal-title":"Intern Med"},{"key":"R12-20260107","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4081\/reumatismo.2020.1353","article-title":"The place of 18F FDG PET\/CT in the management of patients with eosinophilic fasciitis: a case report","volume":"72","author":"Belfeki","year":"2021","journal-title":"Reumatismo"},{"key":"R13-20260107","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00259-019-04571-6","article-title":"Diagnostic performance of 18F-FDG PET\/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis","volume":"47","author":"Treglia","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-20260107","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.ijid.2020.02.017","article-title":"Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in active and latent tuberculosis","volume":"92S","author":"Priftakis","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R15-20260107","doi-asserted-by":"crossref","first-page":"102356","DOI":"10.1016\/j.parint.2021.102356","article-title":"PET\/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis","volume":"83","author":"Husmann","year":"2021","journal-title":"Parasitol Int"},{"key":"R16-20260107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eimc.2021.11.013","article-title":"Impact of 18F-FDG-PET\/CT on the management of Staphylococcus aureus bacteraemia: a retrospective observational study","volume":"41","author":"Suanzes","year":"2023","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"R17-20260107","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s00261-017-1230-4","article-title":"CT and MRI findings in focal eosinophilic infiltration of the liver","volume":"42","author":"Guo","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"R18-20260107","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00259-023-06557-x","article-title":"[18F]FDG PET\/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica","volume":"51","author":"Allard","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-20260107","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.122.265016","article-title":"Role of 18F-FDG PET\/CT in large vessel vasculitis and polymyalgia rheumatica","volume":"64","author":"Slart","year":"2023","journal-title":"J Nucl Med"},{"key":"R20-20260107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2013.09.009","article-title":"FDG-PET\/CT in patients with ANCA-associated vasculitis: case-series and literature review","volume":"13","author":"Soussan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R21-20260107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2967\/jnmt.118.209957","article-title":"18F-FDG PET\/CT for the evaluation of primary eosinophilic granuloma of the hypothalamus","volume":"46","author":"Eshghi","year":"2018","journal-title":"J Nucl Med Technol"},{"key":"R22-20260107","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12149-022-01749-1","article-title":"Clinical value of 18F-FDG PET\/CT in IgG4-related disease","volume":"36","author":"Bai","year":"2022","journal-title":"Ann Nucl Med"},{"key":"R23-20260107","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/RLU.0000000000005094","article-title":"Eosinophilic fasciitis illustrated by 18 F-FDG PET\/CT","volume":"49","author":"Fevrier","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R24-20260107","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.semnuclmed.2022.08.004","article-title":"FDG PET\/CT Imaging of sarcoidosis","volume":"53","author":"R\u00e9gis","year":"2023","journal-title":"Semin Nucl Med"},{"key":"R25-20260107","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12149-023-01896-z","article-title":"Role of PET\/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review","volume":"38","author":"Singh","year":"2024","journal-title":"Ann Nucl Med"},{"key":"R26-20260107","doi-asserted-by":"crossref","first-page":"1069102","DOI":"10.3389\/fmed.2022.1069102","article-title":"Kimura\u2019s disease: a clinicopathological study of 23 cases","volume":"9","author":"Lee","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R27-20260107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00000478-200404000-00010","article-title":"Kimura disease: a clinicopathologic study of 21 cases","volume":"28","author":"Chen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R28-20260107","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/RLU.0b013e3182a77c99","article-title":"18F-FDG PET\/CT for staging and detection of extramedullary organ involvement in chronic myelomonocytic leukemia","volume":"39","author":"Derlin","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R29-20260107","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archderm.142.5.577","article-title":"Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography","volume":"142","author":"Tsai","year":"2006","journal-title":"Arch Dermatol"},{"key":"R30-20260107","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R31-20260107","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/cea.13889","article-title":"The causes of a peripheral blood eosinophilia in a secondary care setting","volume":"51","author":"Wardlaw","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"R32-20260107","doi-asserted-by":"crossref","first-page":"103219","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: a review","volume":"22","author":"White","year":"2023","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T19:00:31Z","timestamp":1767812431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006177"}},"subtitle":["An 11-year Single-center Experience"],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006177","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"2025-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}